file1
,
file2
, etc. all in the same folder or directory;
first, locate one of the files with the [Browse...] button. Then alter the
file path in the box above to include '*' character (eg. file*
).
Wildcard '?' to blanket only one character works too.Historiographs |
Grand Totals: LCS 17722, GCS 106366, CR 136943 Collection span: 1963 - 2012 | |
Word(i) List (4568) Word count: 24159, All words count: 34321 |
# | Word | Recs | TLCS | TGCS |
---|---|---|---|---|
1801 | LIGAND-TREATED | 1 | 2 | 41 |
1802 | NOTES | 2 | 5 | 41 |
1803 | P21 | 1 | 2 | 41 |
1804 | PRECEDES | 1 | 2 | 41 |
1805 | PRECLINICAL | 2 | 2 | 41 |
1806 | PREDOMINANCE | 1 | 1 | 41 |
1807 | PULSE | 2 | 3 | 41 |
1808 | REJECTED | 2 | 1 | 41 |
1809 | REPLICATIVE | 1 | 2 | 41 |
1810 | RHEUMATOID-ARTHRITIS | 2 | 0 | 41 |
1811 | SENESCENCE | 1 | 2 | 41 |
1812 | SEROTYPING | 1 | 22 | 41 |
1813 | SPLEEN-CELLS | 3 | 13 | 41 |
1814 | UNIFYING | 1 | 26 | 41 |
1815 | WAF1 | 1 | 2 | 41 |
1816 | XENOREACTIVITY | 1 | 1 | 41 |
1817 | ACT | 2 | 0 | 40 |
1818 | AORTIC-ANEURYSM | 1 | 0 | 40 |
1819 | AXOTOMY | 1 | 2 | 40 |
1820 | CONCOMITANT | 2 | 4 | 40 |
1821 | CONTROVERSIES | 1 | 4 | 40 |
1822 | FAILED | 1 | 2 | 40 |
1823 | GENETICALLY | 2 | 8 | 40 |
1824 | HISTOLOGY | 2 | 12 | 40 |
1825 | IMMUNOLOGICALLY | 1 | 4 | 40 |
1826 | INFUSED | 2 | 17 | 40 |
1827 | MATE | 1 | 2 | 40 |
1828 | MOLECULAR-DYNAMICS | 1 | 2 | 40 |
1829 | OPTION | 2 | 2 | 40 |
1830 | PHA | 2 | 11 | 40 |
# | Word | Recs | TLCS | TGCS |
1831 | PREOPERATIVE | 4 | 1 | 40 |
1832 | PRIMED | 4 | 3 | 40 |
1833 | PROGRAMMED | 2 | 5 | 40 |
1834 | REPAIR | 1 | 0 | 40 |
1835 | RETAINED | 1 | 2 | 40 |
1836 | SHUNT | 1 | 0 | 40 |
1837 | SINUSOIDAL | 4 | 2 | 40 |
1838 | SONS | 1 | 2 | 40 |
1839 | SYNTHESIZED | 1 | 2 | 40 |
1840 | TWO-WAY | 3 | 14 | 40 |
1841 | WHENEVER | 1 | 0 | 40 |
1842 | ADJUVANTS | 1 | 0 | 39 |
1843 | ALLERGIC | 4 | 3 | 39 |
1844 | ASPIRATION | 1 | 2 | 39 |
1845 | AVOIDANCE | 1 | 2 | 39 |
1846 | DECONTAMINATION | 1 | 0 | 39 |
1847 | FINE-NEEDLE | 1 | 2 | 39 |
1848 | FLAPS | 3 | 0 | 39 |
1849 | LIMBAL | 2 | 0 | 39 |
1850 | MEDICATIONS | 1 | 1 | 39 |
1851 | NEITHER | 1 | 10 | 39 |
1852 | NOR | 1 | 10 | 39 |
1853 | OX-62 | 1 | 3 | 39 |
1854 | PRIMING | 2 | 1 | 39 |
1855 | PROMOTER | 2 | 3 | 39 |
1856 | PSYCHIATRIC | 2 | 0 | 39 |
1857 | RECOMBINANT | 1 | 3 | 39 |
1858 | REDUCE | 4 | 2 | 39 |
1859 | THYMOCYTE | 3 | 3 | 39 |
1860 | TUMOURS | 1 | 0 | 39 |
# | Word | Recs | TLCS | TGCS |
1861 | VIRAL-INFECTION | 1 | 3 | 39 |
1862 | ADAPTABLE | 1 | 0 | 38 |
1863 | BEAD-BASED | 1 | 0 | 38 |
1864 | BIOAVAILABILITY | 2 | 0 | 38 |
1865 | COLLAGEN-INDUCED | 2 | 7 | 38 |
1866 | CONTENT | 6 | 8 | 38 |
1867 | COUNTS | 1 | 6 | 38 |
1868 | DIABETIC | 6 | 1 | 38 |
1869 | EX-VIVO | 2 | 5 | 38 |
1870 | IMMUNOASSAY | 1 | 0 | 38 |
1871 | L-SELECTIN-DEPENDENT | 1 | 1 | 38 |
1872 | MAINTAINS | 2 | 20 | 38 |
1873 | MICRO-FLOW | 1 | 0 | 38 |
1874 | OCCUPANCY | 1 | 1 | 38 |
1875 | ON-CHIP | 1 | 0 | 38 |
1876 | PHAGOCYTIC | 2 | 1 | 38 |
1877 | POLYSTYRENE | 1 | 0 | 38 |
1878 | PRECURSOR | 1 | 0 | 38 |
1879 | PSYCHOLOGICAL | 2 | 2 | 38 |
1880 | REDUCING | 1 | 6 | 38 |
1881 | RESTORATION | 1 | 24 | 38 |
1882 | REVISITED | 4 | 7 | 38 |
1883 | SPLEEN-DERIVED | 1 | 24 | 38 |
1884 | ACCUMULATE | 1 | 1 | 37 |
1885 | ADULT-RAT | 2 | 11 | 37 |
1886 | AGE | 3 | 2 | 37 |
1887 | ALTERATIONS | 4 | 8 | 37 |
1888 | ANTIBIOTICS | 1 | 2 | 37 |
1889 | BARRIERS | 3 | 1 | 37 |
1890 | BLOOD-CONCENTRATIONS | 1 | 6 | 37 |
# | Word | Recs | TLCS | TGCS |
1891 | CD25 | 3 | 4 | 37 |
1892 | CELL-FREE | 2 | 4 | 37 |
1893 | COMPARABLE | 1 | 1 | 37 |
1894 | HPLC-MS | 1 | 6 | 37 |
1895 | IN-SITU | 2 | 15 | 37 |
1896 | MEIA | 1 | 6 | 37 |
1897 | MIGRATE | 1 | 1 | 37 |
1898 | OPTIMISE | 1 | 0 | 37 |
1899 | PERIPORTAL | 1 | 1 | 37 |
1900 | PRIORITIZATION | 1 | 2 | 37 |
1901 | RENALTRANSPLANT | 1 | 0 | 37 |
1902 | SAMPLES | 3 | 4 | 37 |
1903 | SOURCE | 3 | 10 | 37 |
1904 | ACTIVATION-INDUCED | 1 | 5 | 36 |
1905 | AID | 3 | 10 | 36 |
1906 | ANTILYMPHOCYTE-SERUM | 3 | 12 | 36 |
1907 | CELL-DEATH | 1 | 5 | 36 |
1908 | CELL-POPULATIONS | 1 | 3 | 36 |
1909 | CROHN | 1 | 3 | 36 |
1910 | DONOR-AND | 2 | 5 | 36 |
1911 | DRUG-INDUCED | 3 | 3 | 36 |
1912 | EXCISION | 1 | 0 | 36 |
1913 | FINDINGS | 7 | 8 | 36 |
1914 | FOLLOWUP | 1 | 6 | 36 |
1915 | GRAFT-AND | 2 | 0 | 36 |
1916 | HOST-SPECIFIC | 2 | 0 | 36 |
1917 | IMMUNOREGULATORY | 3 | 15 | 36 |
1918 | INFLUENCES | 1 | 0 | 36 |
1919 | NETWORK | 3 | 4 | 36 |
1920 | NEUROTROPHIC | 2 | 0 | 36 |
# | Word | Recs | TLCS | TGCS |
1921 | NOVO | 5 | 3 | 36 |
1922 | OUTFLOW | 1 | 0 | 36 |
1923 | PRIMER | 3 | 11 | 36 |
1924 | SERIAL | 3 | 10 | 36 |
1925 | STEROID-INDUCED | 3 | 1 | 36 |
1926 | THERMODILUTION | 1 | 0 | 36 |
1927 | ALLOIMMUNE | 5 | 10 | 35 |
1928 | BOND-CLEAVAGE | 1 | 2 | 35 |
1929 | C8-C10 | 1 | 2 | 35 |
1930 | CARBON | 1 | 2 | 35 |
1931 | CLUE | 1 | 2 | 35 |
1932 | CROSS-VALIDATION | 1 | 3 | 35 |
1933 | CYP3A4 | 1 | 5 | 35 |
1934 | DEPRESSION | 2 | 2 | 35 |
1935 | EFFECTIVE | 4 | 1 | 35 |
1936 | FACE | 3 | 0 | 35 |
1937 | FETO-MATERNAL | 1 | 2 | 35 |
1938 | GASTRO-INTESTINAL | 1 | 0 | 35 |
1939 | GRAFT-RESIDENT | 2 | 1 | 35 |
1940 | HIDDEN | 1 | 2 | 35 |
1941 | HIGH-PERMEABILITY | 1 | 1 | 35 |
1942 | HUMORAL-FACTORS | 1 | 0 | 35 |
1943 | ISOZYMES | 1 | 5 | 35 |
1944 | LOW-SOLUBILITY | 1 | 1 | 35 |
1945 | MAY | 3 | 21 | 35 |
1946 | MODULATORY | 1 | 18 | 35 |
1947 | NON-STEROID | 1 | 7 | 35 |
1948 | P-GLYCOPROTEIN | 1 | 1 | 35 |
1949 | PERIODIC | 1 | 1 | 35 |
1950 | PERMEABILITY | 1 | 1 | 35 |
# | Word | Recs | TLCS | TGCS |
1951 | PREDICT | 2 | 16 | 35 |
1952 | PROGNOSTIC | 4 | 4 | 35 |
1953 | PROGRAF | 2 | 4 | 35 |
1954 | PROPENSITY | 1 | 2 | 35 |
1955 | REMARKABLE | 1 | 2 | 35 |
1956 | REPLICATION | 2 | 6 | 35 |
1957 | SCLEROSIS | 2 | 1 | 35 |
1958 | SEGMENT | 2 | 2 | 35 |
1959 | TERMINAL | 1 | 1 | 35 |
1960 | WALL | 1 | 0 | 35 |
1961 | ALLOIMMUNITY | 1 | 1 | 34 |
1962 | ALLOTRANSPLANTED | 2 | 4 | 34 |
1963 | ALS | 6 | 6 | 34 |
1964 | ANTI-TUMOR-PROMOTING | 1 | 2 | 34 |
1965 | ANTIGENEMIA | 1 | 1 | 34 |
1966 | ARTERIES | 2 | 6 | 34 |
1967 | BANFF | 1 | 3 | 34 |
1968 | BRIGHT | 2 | 2 | 34 |
1969 | CALCIUM | 2 | 9 | 34 |
1970 | CONGENITAL | 1 | 0 | 34 |
1971 | CYTOMEGALOVIRUS-FREE | 1 | 1 | 34 |
1972 | DEVELOPMENTAL | 1 | 1 | 34 |
1973 | DONATION | 2 | 0 | 34 |
1974 | EVOKED | 1 | 1 | 34 |
1975 | EXONUCLEASE-RELEASED | 1 | 0 | 34 |
1976 | FACTOR-INDUCED | 1 | 0 | 34 |
1977 | FIBROBLASTS | 1 | 4 | 34 |
1978 | GANCICLOVIR | 1 | 1 | 34 |
1979 | GLYCOSURIA | 1 | 12 | 34 |
1980 | GUIDANCE | 1 | 1 | 34 |
# | Word | Recs | TLCS | TGCS |
1981 | HISTAMINE | 1 | 0 | 34 |
1982 | HLA-DQB1 | 1 | 0 | 34 |
1983 | HYPERGLYCEMIA | 1 | 12 | 34 |
1984 | LACK | 3 | 2 | 34 |
1985 | LIVER-ALLOGRAFT | 1 | 3 | 34 |
1986 | MARKED | 2 | 2 | 34 |
1987 | MAST | 1 | 0 | 34 |
1988 | MONTHS | 4 | 3 | 34 |
1989 | MYELOID | 5 | 5 | 34 |
1990 | POLAR | 1 | 5 | 34 |
1991 | POLYMORPHONUCLEAR | 2 | 8 | 34 |
1992 | POPULATIONS | 4 | 5 | 34 |
1993 | PP65 | 1 | 1 | 34 |
1994 | RECIPIENT-DERIVED | 2 | 3 | 34 |
1995 | RETICULOENDOTHELIAL | 1 | 1 | 34 |
1996 | SCHEMA | 1 | 3 | 34 |
1997 | SEROPOSITIVE | 1 | 1 | 34 |
1998 | SITE-SPECIFIC | 1 | 0 | 34 |
1999 | TRANSPORT | 1 | 0 | 34 |
2000 | UNIQUE | 3 | 2 | 34 |